Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ELYM similar filings
- 27 Jun 24 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
- 26 Jun 24 Submission of Matters to a Vote of Security Holders
- 12 Jun 24 Departure of Directors or Certain Officers
- 11 Apr 24 Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in Registration Statement Nos. 333-278328, 333-270304, 333-263347, and 333-258771 on Form S-8 of Eliem Therapeutics, Inc. of our report dated May 16, 2024, relating to the financial statements of Tenet Medicines, Inc. appearing in this Current Report on Form 8-K dated June 27, 2024.
/s/ Deloitte & Touche LLP
San Diego, CA
June 27, 2024